Long Focus Capital Management, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Long Focus Capital Management, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,240,871
-14.9%
2,470,521
+31.6%
0.40%
-33.2%
Q2 2023$13,212,771
+4.9%
1,876,814
-9.0%
0.60%
-15.6%
Q1 2023$12,597,684
-4.4%
2,061,8140.0%0.71%
-21.6%
Q4 2022$13,174,991
+46.9%
2,061,814
+120.3%
0.91%
+4.0%
Q3 2022$8,967,000
-50.0%
936,000
-42.4%
0.87%
-53.5%
Q2 2022$17,940,000
+52.8%
1,625,000
+130.5%
1.88%
+24.7%
Q1 2022$11,738,000
+17.1%
705,000
+34.3%
1.51%
+13.6%
Q4 2021$10,022,000525,0001.33%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders